NCT00257647View on ClinicalTrials.gov

Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

November 30, 2007

Conditions
Chronic Myeloid Leukemia
Interventions
OTHER

SV40 vectors carrying siRNA

in vitro only use of gene therapy

Trial Locations (1)

IL91120

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Hadassah Medical Organization

OTHER

NCT00257647 - Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML) | Biotech Hunter | Biotech Hunter